Inventor · disambiguated record
Sabine Maier
Also filed as: MAIER SABINE
8 granted patents·18 pending applications·20 citations·filing 2002–2024
82Inventor score
Top patents by PatentIndex Score
26 records- 0190US11919957B2Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 5, 2024·4 cites·13 claims
- 0287US12466888B2Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2024·Granted Nov 11, 2025·1 cites·19 claims
- 0374US12479917B2Methods of treating NSCLC comprising administering platinum doublet chemotherapy followed by an anti-PD-1 antibody and an anti-CTLA-4 antibodyBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 25, 2025·3 cites·20 claims
- 0473US8101359B2Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapyFOEKENS JOHN·Filed 2003·Granted Jan 24, 2012·6 cites·14 claims
- 0573US2025059610A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0672US9017944B2Methods for the prognosis of breast cancerFOEKENS JOHN·Filed 2004·Granted Apr 28, 2015·6 cites·10 claims
- 0771US2015275312A1Method and nucleic acids for the analysis of a colon cell proliferative disorderEPIGENOMICS AG·Filed 2014·Application pending·0 cites
- 0868US2014179563A1Method and Nucleic Acids for the Analysis of Colorectal Cell Proliferative DisordersEPIGENOMICS AG·Filed 2014·Application pending·0 cites
- 0967US2023295737A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1065US2024190963A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1160US2006246433A1Method and nucleic acids for the analysis of a colon cell proliferative disorderEPIGENOMICS AG·Filed 2003·Application pending·0 cites
- 1259US2020239577A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1353US2006024684A1Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patientsEPIGENOMICS AG·Filed 2004·Application pending·0 cites
- 1451US2021101980A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1551US2012184455A1Method and Nucleic Acids for the Improved Treatment of Breast Cell Proliferative DisordersFOEKENS JOHN·Filed 2012·Application pending·0 cites
- 1651US2006292564A1Method and nucleic acids for the analysis of breast cell proliferative disordersEPIGENOMICS AG·Filed 2003·Application pending·0 cites
- 1748US2007128592A1Method and nucleic acids for the analysis of a lung cell proliferative disorderEPIGENOMICS AG·Filed 2002·Application pending·0 cites
- 1845US10053735B2Markers for the prediction of outcome of anthracycline treatmentFOEKENS JOHN·Filed 2006·Granted Aug 21, 2018·0 cites·12 claims
- 1944US2021032344A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2043US2009269736A1Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patientsEPIGENOMICS AG·Filed 2005·Application pending·0 cites
- 2142US2008171318A1Epigenetic Methods and Nucleic Acids for the Detection of Lung Cell Proliferative DisordersEPIGENOMICS AG·Filed 2005·Application pending·0 cites
- 2242US2004234973A1Methods and nucleic acids for the analysis of hematopoietic cell proliferative disordersFiled 2002·Application pending·0 cites
- 2340US9988683B2Method and nucleic acids for the analysis of colon cell proliferative disordersADORJAN PETER·Filed 2010·Granted Jun 5, 2018·0 cites·35 claims
- 2439US2004082079A1Low affinity screening methodFiled 2002·Application pending·0 cites
- 2533US8691503B2Method and nucleic acids for the analysis of colorectal cell proliferative disordersADORJAN PETER·Filed 2003·Granted Apr 8, 2014·0 cites·4 claims
- 2632US2006234224A1Method and nucleic acids for the analysis of colon cell proliferative disordersADORJAN PETER·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sabine Maier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →